Home » Topics » Drugs » Immuno-oncology

Immuno-oncology
RSS

Genovax sells GX-301 cancer vaccine to Mediolanum Farmaceutici

Dec. 5, 2012

Cel-Sci updates on phase III Multikine immunotherapy trial

Dec. 3, 2012

Phase II trial of pancreas cancer vaccines completes enrollment

Nov. 30, 2012

First clinical data on RG-7212 show target modulation and signs of efficacy

Nov. 29, 2012

Japanese scientists present new humanized monoclonal antibodies

Nov. 28, 2012

Adcetris receives FDA orphan drug designation for mycosis fungoides

Nov. 27, 2012

Chugai and Nippon Shinyaku agree on GA-101 development for NHL in Japan

Nov. 27, 2012

Preclinical assessment of a novel bispecific antibody for the treatment of prostate cancer

Nov. 27, 2012

A novel bispecific antibody shows tumor specificity in vivo

Nov. 21, 2012

Immunovative Therapies expands collaboration with the University of Arizona

Nov. 16, 2012

Popular Stories

Today's news in brief
BioWorld
SCAN is core circuit affected in Parkinson’s disease
BioWorld Science
Parkinson’s disease (PD) is a neurodegenerative disorder that affects movement, and tremor is one of its signatures. But it is a much more wide-ranging disorder,...
TL1A is overexpressed in hidradenitis suppurativa
BioWorld Science
Despite the availability of advanced therapeutic options, about 40%-50% of patients with hidradenitis suppurativa do not achieve significant improvement in...
Astellas’ ASP-2246 shows promise in stroke management
BioWorld Science
Astellas Pharma Inc. recently presented data regarding ASP-2246, a drug candidate comprised of an mRNA encoding the transcription factor NeuroD1 encapsulated in...
News in brief
BioWorld Asia
BioWorld Asia briefs for Feb. 10, 2026